Fecal bacteriome in pediatric celiac disease in relation to the gluten-free diet and PFAS exposure: a multiomic study

Celiac disease is a condition where the body's immune system mistakenly attacks the small intestine whenever a person eats gluten, a protein found in wheat, barley, and rye. For those with this condition, the only effective treatment is a strict, lifelong diet that completely excludes gluten. While this diet allows the gut to heal and symptoms to fade, doctors and scientists have long wondered if the internal ecosystem of the gut fully recovers. The gut is home to trillions of tiny organisms, mostly bacteria, that help digest food and train the immune system. In recent years, researchers have also begun to look at how modern environmental chemicals might interfere with this delicate balance. One group of these chemicals, known as per- and polyfluoroalkyl substances, or PFAS, are synthetic compounds used in everything from non-stick cookware to food packaging. Because these chemicals do not break down easily in the environment or the body, they are sometimes called "forever chemicals," and scientists are investigating whether they might disrupt the gut bacteria or the immune system in ways that contribute to diseases like celiac.

A team of researchers in the Czech Republic decided to investigate these questions by following a group of children with celiac disease over a period of time. They wanted to see what happened to the bacteria in their stool when the children started a gluten-free diet, and whether exposure to PFAS chemicals played a role in their gut health. The study involved twenty-three children who had just been diagnosed with celiac disease and twenty-three other children who did not have the condition. The researchers collected blood and stool samples from the celiac group at the moment of diagnosis, and then again after the children had been on a gluten-free diet for four to six months, and finally after twelve to eighteen months. They also checked the blood of all the children for levels of PFAS and measured specific antibodies in the blood and traces of gluten in the stool to see how well the children were sticking to their diet.

The results showed that at the time of diagnosis, the children with celiac disease had a gut bacterial community that was less diverse than that of the healthy children. Their guts contained fewer of the beneficial bacteria that are known to produce healthy compounds for the body, such as short-chain fatty acids, and had higher levels of certain bacteria that are often linked to inflammation. When the children began their gluten-free diet, their blood tests showed that their immune system was calming down, and their diet adherence was excellent, as confirmed by tests that looked for traces of gluten in their stool and changes in blood antibodies. However, the story of their gut bacteria was more complicated. While some of the beneficial bacteria began to increase and the harmful ones began to decrease after a few months on the diet, the bacterial community did not fully return to the state seen in the healthy children, even after more than a year of strict dieting. In fact, some of the improvements seen at the four-to-six-month mark seemed to slip back slightly by the twelve-to-eighteen-month mark, suggesting that the recovery of the gut ecosystem is not a simple, straight line toward health.

The researchers also looked closely at the levels of PFAS chemicals in the children's blood. They found that the total amount of these chemicals was similar in the children with celiac disease and the healthy children, meaning that higher exposure to these chemicals did not appear to be a major factor in causing the disease in this group. However, when they dug deeper into the data, they discovered a different kind of connection. In the children with celiac disease, specific types of PFAS chemicals were linked to the levels of certain bacteria in the gut and to the strength of the immune response. For instance, higher levels of certain PFAS were associated with lower levels of beneficial bacteria that produce short-chain fatty acids. These links were not found in the healthy children, suggesting that the gut bacteria of children with celiac disease might react differently to these environmental chemicals.

The study concludes that while a gluten-free diet is essential for treating celiac disease, it may not be enough to completely restore the gut's bacterial world to a healthy state. The gut bacteria of these children show a dynamic pattern of change that improves but does not fully normalize, even when the diet is followed perfectly. The research also highlights that while PFAS exposure might not be the primary cause of celiac disease in these children, it could still interact with the gut bacteria and immune system in ways that are specific to the disease. These findings suggest that treating celiac disease might eventually require looking beyond just the diet, perhaps considering how to help the gut bacteria recover more fully or how environmental factors might be influencing the gut's ability to heal. The work underscores that the human gut is a complex system where diet, bacteria, and environmental chemicals all play a part in health and disease.